University of Pennsylvania medical student Yentli Soto Albrecht is on a mission to save the lives of those battling ALS, like ...
Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic ...
Veteran journalist Oren Nahari revealed he has ALS, a severe degenerative neurological disease. How many Israelis are ...
Researchers have uncovered a surprising connection between gut bacteria and the development of ALS and frontotemporal ...
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b ...